Molecular physiology of glucagon-like peptide-1 insulin secretagogue action in pancreatic β cells.

[1]  E. Tomás,et al.  GLP-1-derived nonapeptide GLP-1(28–36)amide targets to mitochondria and suppresses glucose production and oxidative stress in isolated mouse hepatocytes , 2011, Regulatory Peptides.

[2]  Thembi Mdluli,et al.  Snapin mediates incretin action and augments glucose-dependent insulin secretion. , 2011, Cell metabolism.

[3]  Z. Israili.  Advances in the treatment of type 2 diabetes mellitus. , 2011, American journal of therapeutics.

[4]  K. Smidt,et al.  Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS‐1E beta‐cells , 2011, British journal of pharmacology.

[5]  O. Chepurny,et al.  Epac2‐dependent mobilization of intracellular Ca2+ by glucagon‐like peptide‐1 receptor agonist exendin‐4 is disrupted in β‐cells of phospholipase C‐ɛ knockout mice , 2010, The Journal of physiology.

[6]  A. Galione,et al.  NAADP as an intracellular messenger regulating lysosomal calcium-release channels. , 2010, Biochemical Society transactions.

[7]  M. Tominaga,et al.  Lack of TRPM2 Impaired Insulin Secretion and Glucose Metabolisms in Mice , 2010, Diabetes.

[8]  A. Galione,et al.  An emerging role for NAADP-mediated Ca2+ signaling in the pancreatic β-cell , 2010, Islets.

[9]  F. Ashcroft,et al.  A mutation in KCNJ11 causing human hyperinsulinism (Y12X) results in a glucose-intolerant phenotype in the mouse , 2010, Diabetologia.

[10]  J. Miyazaki,et al.  Rim2alpha determines docking and priming states in insulin granule exocytosis. , 2010, Cell metabolism.

[11]  J. Holst,et al.  The Glucagonostatic and Insulinotropic Effects of Glucagon-Like Peptide 1 Contribute Equally to Its Glucose-Lowering Action , 2010, Diabetes.

[12]  Susan S. Taylor,et al.  Dissecting the cAMP‐inducible allosteric switch in protein kinase A RIα , 2010, Protein science : a publication of the Protein Society.

[13]  R. Penner,et al.  TRPM5 regulates glucose-stimulated insulin secretion , 2010, Pflügers Archiv - European Journal of Physiology.

[14]  O. Chepurny,et al.  PKA-dependent potentiation of glucose-stimulated insulin secretion by Epac activator 8-pCPT-2'-O-Me-cAMP-AM in human islets of Langerhans. , 2010, American journal of physiology. Endocrinology and metabolism.

[15]  O. Chepurny,et al.  Facilitation of β-cell KATP channel sulfonylurea sensitivity by a cAMP analog selective for the cAMP-regulated guanine nucleotide exchange factor Epac , 2010, Islets.

[16]  K. Lemaire,et al.  Loss of high-frequency glucose-induced Ca2+ oscillations in pancreatic islets correlates with impaired glucose tolerance in Trpm5−/− mice , 2010, Proceedings of the National Academy of Sciences.

[17]  Taufiq Rahman,et al.  Regulation of Inositol 1,4,5-Trisphosphate Receptors by cAMP Independent of cAMP-dependent Protein Kinase , 2010, The Journal of Biological Chemistry.

[18]  J. Holst,et al.  Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: new advances , 2010, Current opinion in endocrinology, diabetes, and obesity.

[19]  E. Tomás,et al.  Insulin-like actions of glucagon-like peptide-1: a dual receptor hypothesis , 2010, Trends in Endocrinology & Metabolism.

[20]  G. Hockerman,et al.  Cav1.2 and Cav1.3 Are Differentially Coupled to Glucagon-Like Peptide-1 Potentiation of Glucose-Stimulated Insulin Secretion in the Pancreatic β-Cell Line INS-1 , 2009, Journal of Pharmacology and Experimental Therapeutics.

[21]  O. Chepurny,et al.  Glucose-dependent potentiation of mouse islet insulin secretion by Epac activator 8-pCPT-2’-O-Me-cAMP-AM , 2009, Islets.

[22]  Robert M. Jones,et al.  GPR119 agonists for the treatment of type 2 diabetes , 2009, Expert opinion on therapeutic patents.

[23]  L. Eliasson,et al.  Truncation of SNAP-25 reduces the stimulatory action of cAMP on rapid exocytosis in insulin-secreting cells. , 2009, American journal of physiology. Endocrinology and metabolism.

[24]  B. Ahrén.  Clinical results of treating type 2 diabetic patients with sitagliptin, vildagliptin or saxagliptin--diabetes control and potential adverse events. , 2009, Best practice & research. Clinical endocrinology & metabolism.

[25]  M. Prentki,et al.  Glucagon-Like Peptide-1 Induced Signaling and Insulin Secretion Do Not Drive Fuel and Energy Metabolism in Primary Rodent Pancreatic β-Cells , 2009, PloS one.

[26]  C. Dart,et al.  Exchange protein activated by cAMP (Epac) mediates cAMP‐dependent but protein kinase A‐insensitive modulation of vascular ATP‐sensitive potassium channels , 2009, The Journal of physiology.

[27]  M. Islam.  One hundred fourty years after the discovery of islets by Paul Langerhans, Islets, a new journal dedicated to these mini-organs, is born , 2009, Islets.

[28]  Julie A. Przybyla,et al.  The Intracellular II-III Loops of Cav1.2 and Cav1.3 Uncouple L-Type Voltage-Gated Ca2+ Channels from Glucagon-Like Peptide-1 Potentiation of Insulin Secretion in INS-1 Cells via Displacement from Lipid Rafts , 2009, Journal of Pharmacology and Experimental Therapeutics.

[29]  T. Shibasaki,et al.  Critical role of the N‐terminal cyclic AMP‐binding domain of Epac2 in its subcellular localization and function , 2009, Journal of cellular physiology.

[30]  R. Penner,et al.  TRPM2 Functions as a Lysosomal Ca2+-Release Channel in β Cells , 2009, Science Signaling.

[31]  G. G. Kelley,et al.  Enhanced Rap1 Activation and Insulin Secretagogue Properties of an Acetoxymethyl Ester of an Epac-selective Cyclic AMP Analog in Rat INS-1 Cells , 2009, Journal of Biological Chemistry.

[32]  A. Galione,et al.  NAADP mobilizes calcium from acidic organelles through two-pore channels , 2009, Nature.

[33]  W. Hsu,et al.  TRPM4 impacts on Ca2+ signals during agonist-induced insulin secretion in pancreatic β-cells , 2009, Molecular and Cellular Endocrinology.

[34]  Alexander M. Lewis,et al.  Identification of a chemical probe for NAADP by virtual screening , 2009, Nature chemical biology.

[35]  B. Blaxall,et al.  Epac and Phospholipase Cϵ Regulate Ca2+ Release in the Heart by Activation of Protein Kinase Cϵ and Calcium-Calmodulin Kinase II* , 2009, Journal of Biological Chemistry.

[36]  J. Bos,et al.  Cover Picture: 8‐pCPT‐2′‐O‐Me‐cAMP‐AM: An Improved Epac‐Selective cAMP Analogue (ChemBioChem 13/2008) , 2008 .

[37]  C. Arrieumerlou,et al.  Glucose-induced cyclic AMP oscillations regulate pulsatile insulin secretion. , 2008, Cell metabolism.

[38]  L. Eliasson,et al.  CaV1.2 rather than CaV1.3 is coupled to glucose-stimulated insulin secretion in INS-1 832/13 cells. , 2008, Journal of molecular endocrinology.

[39]  J. Holst,et al.  Replacing SUs with incretin-based therapies for type 2 diabetes mellitus: challenges and feasibility. , 2008, IDrugs : the investigational drugs journal.

[40]  T. Elhadd,et al.  Incretin based therapies for type 2 diabetes mellitus. , 2008, Journal of the Indian Medical Association.

[41]  Robert M. Jones,et al.  A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release. , 2008, Endocrinology.

[42]  S. Takasawa,et al.  Generation of Nicotinic Acid Adenine Dinucleotide Phosphate and Cyclic ADP-Ribose by Glucagon-Like Peptide-1 Evokes Ca2+ Signal That Is Essential for Insulin Secretion in Mouse Pancreatic Islets , 2008, Diabetes.

[43]  O. Chepurny,et al.  Role of the cAMP sensor Epac as a determinant of KATP channel ATP sensitivity in human pancreatic β‐cells and rat INS‐1 cells , 2008, The Journal of physiology.

[44]  J. Miyazaki,et al.  Essential role of Epac2/Rap1 signaling in regulation of insulin granule dynamics by cAMP , 2007, Proceedings of the National Academy of Sciences.

[45]  Louis H Philipson,et al.  Regulation of cAMP dynamics by Ca2+ and G protein-coupled receptors in the pancreatic beta-cell: a computational approach. , 2007, American journal of physiology. Cell physiology.

[46]  L. Sheu,et al.  Interaction Between Munc13-1 and RIM Is Critical for Glucagon-Like Peptide-1–Mediated Rescue of Exocytotic Defects in Munc13-1–Deficient Pancreatic β-Cells , 2007, Diabetes.

[47]  H. Kasai,et al.  Two cAMP‐dependent pathways differentially regulate exocytosis of large dense‐core and small vesicles in mouse β‐cells , 2007, The Journal of physiology.

[48]  Didier Bagnol,et al.  A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release. , 2007, Endocrinology.

[49]  M. Harbeck,et al.  Cell physiology of cAMP sensor Epac , 2006, The Journal of physiology.

[50]  N. Saito,et al.  Glucagon-like Peptide 1 Activates Protein Kinase C through Ca2+-dependent Activation of Phospholipase C in Insulin-secreting Cells* , 2006, Journal of Biological Chemistry.

[51]  M. Tominaga,et al.  TRPM2 activation by cyclic ADP‐ribose at body temperature is involved in insulin secretion , 2006, The EMBO journal.

[52]  M. Lohse,et al.  Interplay of Ca2+ and cAMP Signaling in the Insulin-secreting MIN6 β-Cell Line*[boxs] , 2005, Journal of Biological Chemistry.

[53]  M. Harbeck,et al.  A cAMP and Ca2+ coincidence detector in support of Ca2+-induced Ca2+ release in mouse pancreatic β cells , 2005, The Journal of physiology.

[54]  J. Holst,et al.  Distinct effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 on insulin secretion and gut motility. , 2005, Diabetes.

[55]  G. Holz.  New Insights Concerning the Glucose-dependent Insulin Secretagogue Action of Glucagon-like Peptide-1 in Pancreatic β-Cells , 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[56]  O. Chepurny,et al.  Diabetes Outfoxed by GLP-1? , 2005, Science's STKE.

[57]  K. Gillis,et al.  A Highly Ca2+-sensitive Pool of Granules Is Regulated by Glucose and Protein Kinases in Insulin-secreting INS-1 Cells , 2004, The Journal of general physiology.

[58]  T. Shibasaki,et al.  Integration of ATP, cAMP, and Ca2+ signals in insulin granule exocytosis. , 2004, Diabetes.

[59]  X. Lou,et al.  Protein Kinase Activation Increases Insulin Secretion by Sensitizing the Secretory Machinery to Ca2+ , 2004, The Journal of general physiology.

[60]  P. Rorsman,et al.  Glucagon-like peptide-1: regulation of insulin secretion and therapeutic potential. , 2004, Basic & clinical pharmacology & toxicology.

[61]  Holz Gg.  New Insights Concerning the Glucose-dependent Insulin Secretagogue Action of Glucagon-like Peptide-1 in Pancreatic β-Cells , 2004 .

[62]  O. Dyachok,et al.  Ca2+-induced Ca2+ Release via Inositol 1,4,5-trisphosphate Receptors Is Amplified by Protein Kinase A and Triggers Exocytosis in Pancreatic β-Cells* , 2004, Journal of Biological Chemistry.

[63]  T. Hibi,et al.  Transient receptor potential vanilloid subfamily 1 expressed in pancreatic islet beta cells modulates insulin secretion in rats. , 2004, Biochemical and biophysical research communications.

[64]  A. Arredouani,et al.  Atypical Ca2+‐induced Ca2+ release from a sarco‐endoplasmic reticulum Ca2+‐ATPase 3‐dependent Ca2+ pool in mouse pancreatic β‐cells , 2004, The Journal of physiology.

[65]  G. Tufveson,et al.  Ca2+-induced Ca2+ release by activation of inositol 1,4,5-trisphosphate receptors in primary pancreatic beta-cells. , 2004, Cell calcium.

[66]  J. Holst.  Treatment of Type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors , 2004, Expert opinion on emerging drugs.

[67]  T. Shibasaki,et al.  Interaction of ATP Sensor, cAMP Sensor, Ca2+ Sensor, and Voltage-dependent Ca2+ Channel in Insulin Granule Exocytosis* , 2004, Journal of Biological Chemistry.

[68]  P. MacDonald,et al.  Antagonism of Rat β-Cell Voltage-dependent K+ Currents by Exendin 4 Requires Dual Activation of the cAMP/Protein Kinase A and Phosphatidylinositol 3-Kinase Signaling Pathways* , 2003, Journal of Biological Chemistry.

[69]  O. Chepurny,et al.  Glucagon-like peptide-1 synthetic analogs: new therapeutic agents for use in the treatment of diabetes mellitus. , 2003, Current medicinal chemistry.

[70]  F. Varoqueaux,et al.  Regulation of Insulin Exocytosis by Munc13-1* , 2003, Journal of Biological Chemistry.

[71]  N. Dilmac,et al.  Cav1.3 Is Preferentially Coupled to Glucose-Stimulated Insulin Secretion in the Pancreatic β-Cell Line INS-1 , 2003, Journal of Pharmacology and Experimental Therapeutics.

[72]  J. Bos,et al.  Epac-selective cAMP Analog 8-pCPT-2′-O-Me-cAMP as a Stimulus for Ca2+-induced Ca2+ Release and Exocytosis in Pancreatic β-Cells* , 2003, The Journal of Biological Chemistry.

[73]  L. Eliasson,et al.  SUR1 Regulates PKA-independent cAMP-induced Granule Priming in Mouse Pancreatic B-cells , 2003, The Journal of general physiology.

[74]  G. Rutter,et al.  Glucagon-like peptide-1 mobilizes intracellular Ca2+ and stimulates mitochondrial ATP synthesis in pancreatic MIN6 beta-cells. , 2003, The Biochemical journal.

[75]  G. Holz,et al.  Amplification of exocytosis by Ca2+‐induced Ca2+ release in INS‐1 pancreatic β cells , 2003, The Journal of physiology.

[76]  J. Bryan,et al.  cAMP-activated protein kinase-independent potentiation of insulin secretion by cAMP is impaired in SUR1 null islets. , 2002, Diabetes.

[77]  P. MacDonald,et al.  Glucagon-like peptide-1 receptor activation antagonizes voltage-dependent repolarizing K(+) currents in beta-cells: a possible glucose-dependent insulinotropic mechanism. , 2002, Diabetes.

[78]  S. Døskeland,et al.  A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK , 2002, Nature Cell Biology.

[79]  J. Gromada,et al.  Sulfonylurea Receptor Type 1 Knock-out Mice Have Intact Feeding-stimulated Insulin Secretion despite Marked Impairment in Their Response to Glucose* , 2002, The Journal of Biological Chemistry.

[80]  P. Light,et al.  Glucagon-like peptide-1 inhibits pancreatic ATP-sensitive potassium channels via a protein kinase A- and ADP-dependent mechanism. , 2002, Molecular endocrinology.

[81]  L. Eliasson,et al.  A subset of 50 secretory granules in close contact with L-type Ca2+ channels accounts for first-phase insulin secretion in mouse beta-cells. , 2002, Diabetes.

[82]  T. Shibasaki,et al.  Critical Role of cAMP-GEFII·Rim2 Complex in Incretin-potentiated Insulin Secretion* , 2001, The Journal of Biological Chemistry.

[83]  O. Chepurny,et al.  cAMP‐regulated guanine nucleotide exchange factor II (Epac2) mediates Ca2+‐induced Ca2+ release in INS‐1 pancreatic β‐cells , 2001, The Journal of physiology.

[84]  Uri Ashery,et al.  Phosphorylation of Snapin by PKA modulates its interaction with the SNARE complex , 2001, Nature Cell Biology.

[85]  J. Henquin,et al.  Triggering and amplifying pathways of regulation of insulin secretion by glucose. , 2000, Diabetes.

[86]  Yasuhiro Sunaga,et al.  cAMP-GEFII is a direct target of cAMP in regulated exocytosis , 2000, Nature Cell Biology.

[87]  J. Habener,et al.  The glucagon-like peptides. , 1999, Endocrine reviews.

[88]  J. Habener,et al.  cAMP-dependent mobilization of intracellular Ca2+ stores by activation of ryanodine receptors in pancreatic beta-cells. A Ca2+ signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37). , 1999, The Journal of biological chemistry.

[89]  Z. Sheng,et al.  Snapin: a SNARE–associated protein implicated in synaptic transmission , 1999, Nature Neuroscience.

[90]  Y. Miyashita,et al.  Post-priming actions of ATP on Ca2+-dependent exocytosis in pancreatic beta cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[91]  J. Habener,et al.  A role for Ca2+-sensitive nonselective cation channels in regulating the membrane potential of pancreatic beta-cells. , 1998, Diabetes.

[92]  T. Yada,et al.  [Ca2+]i-reducing action of cAMP in rat pancreatic beta-cells: involvement of thapsigargin-sensitive stores. , 1998, The American journal of physiology.

[93]  T. Yada,et al.  [Ca2+]i-reducing action of cAMP in rat pancreatic β-cells: involvement of thapsigargin-sensitive stores. , 1998, American journal of physiology. Cell physiology.

[94]  J. Holst,et al.  Glucagon-Like Peptide 1(7-36) Amide Stimulates Exocytosis in Human Pancreatic β-Cells by Both Proximal and Distal Regulatory Steps in Stimulus-Secretion Coupling , 1998, Diabetes.

[95]  L. Langeberg,et al.  Anchoring of protein kinase A facilitates hormone-mediated insulin secretion. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[96]  L. Eliasson,et al.  Protein kinase A‐dependent and ‐independent stimulation of exocytosis by cAMP in mouse pancreatic B‐cells , 1997, The Journal of physiology.

[97]  J. Habener,et al.  Activation of a cAMP-regulated Ca-Signaling Pathway in Pancreatic -Cells by the Insulinotropic Hormone Glucagon-like Peptide-1 (*) , 1995, The Journal of Biological Chemistry.

[98]  C. Hales,et al.  Regulation of calcium-activated nonselective cation channel activity by cyclic nucleotides in the rat insulinoma cell line, CRI-G1 , 1995, The Journal of Membrane Biology.

[99]  L. Eliasson,et al.  Co‐localization of L‐type Ca2+ channels and insulin‐containing secretory granules and its significance for the initiation of exocytosis in mouse pancreatic B‐cells. , 1995, The EMBO journal.

[100]  J. Habener,et al.  Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37) , 1993, Nature.

[101]  J. Habener,et al.  Signal transduction crosstalk in the endocrine system: pancreatic beta-cells and the glucose competence concept. , 1992, Trends in biochemical sciences.

[102]  N. Sturgess,et al.  Inhibition of a calcium‐activated, non‐selective cation channel, in a rat insulinoma cell line, by adenine derivatives , 1986, FEBS letters.

[103]  M. Nauck.  Incretin-based therapies for type 2 diabetes mellitus: properties, functions, and clinical implications. , 2011, The American journal of medicine.

[104]  A. Galione,et al.  An emerging role for NAADP-mediated Ca 2 + signaling in the pancreatic beta-cell , 2011 .

[105]  M. S. Islam,et al.  Calcium signaling in the islets. , 2010, Advances in experimental medicine and biology.

[106]  T. Kowalski,et al.  GPR119 agonists for the potential treatment of type 2 diabetes and related metabolic disorders. , 2010, Vitamins and hormones.

[107]  O. Chepurny,et al.  Epac-selective cAMP analogs: new tools with which to evaluate the signal transduction properties of cAMP-regulated guanine nucleotide exchange factors. , 2008, Cellular signalling.

[108]  G. Holz,et al.  Synchronizing Ca2+ and cAMP oscillations in pancreatic beta-cells: a role for glucose metabolism and GLP-1 receptors? Focus on "regulation of cAMP dynamics by Ca2+ and G protein-coupled receptors in the pancreatic beta-cell: a computational approach". , 2008, American journal of physiology. Cell physiology.

[109]  Alexander J Stokes,et al.  TRPM4 controls insulin secretion in pancreatic beta-cells. , 2007, Cell calcium.

[110]  A. Wittinghofer,et al.  Capturing cyclic nucleotides in action: snapshots from crystallographic studies , 2007, Nature Reviews Molecular Cell Biology.

[111]  Alexander J Stokes,et al.  TRPM4 controls insulin secretion in pancreatic β-cells , 2007 .

[112]  J. Bos,et al.  Epac as a determinant of ATP-sensitive potassium channel activity in human pancreatic β cells and rat INS-1 cells , 2006 .

[113]  畠山 裕康.  Rapid glucose sensing by protein kinase A for insulin exocytosis in mouse pancreatic islets , 2006 .

[114]  H. Mogami,et al.  Glucagon-Like Peptide 1 Activates Protein Kinase C in a Ca2+-Dependent Manner in Insulin-Secreting Cells , 2006 .

[115]  M. Lohse,et al.  Interplay of Ca2+ and cAMP signaling in the insulin-secreting MIN6 beta-cell line. , 2005, The Journal of biological chemistry.

[116]  G. Holz.  Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell. , 2004, Diabetes.

[117]  N. Dilmac,et al.  Ca v 1.3 is preferentially coupled to glucose-stimulated insulin secretion in the pancreatic beta-cell line INS-1. , 2003, The Journal of pharmacology and experimental therapeutics.

[118]  M. Prentki,et al.  Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor. , 2003, Diabetes.

[119]  P. MacDonald,et al.  Antagonism of rat beta-cell voltage-dependent K+ currents by exendin 4 requires dual activation of the cAMP/protein kinase A and phosphatidylinositol 3-kinase signaling pathways. , 2003, The Journal of biological chemistry.

[120]  M. Prentki,et al.  Glucagon-Like Peptide 1 Induces Pancreatic β-Cell Proliferation Via Transactivation of the Epidermal Growth Factor Receptor , 2003 .

[121]  P. Rorsman,et al.  Glucagon-like peptide I increases cytoplasmic calcium in insulin-secreting beta TC3-cells by enhancement of intracellular calcium mobilization. , 1995, Diabetes.